Arian Lasocki
Imaging features associated with H3 K27-altered and H3 G34-mutant gliomas: a narrative systematic review.
Lasocki, Arian; Abdalla, Gehad; Chow, Geoffrey; Thust, Stefanie C.
Authors
Gehad Abdalla
Geoffrey Chow
Stefanie C. Thust
Abstract
Background
Advances in molecular diagnostics accomplished the discovery of two malignant glioma entities harboring alterations in the H3 histone: diffuse midline glioma, H3 K27-altered and diffuse hemispheric glioma, H3 G34-mutant. Radiogenomics research, which aims to correlate tumor imaging features with genotypes, has not comprehensively examined histone-altered gliomas (HAG). The aim of this research was to synthesize the current published data on imaging features associated with HAG.
Methods
A systematic search was performed in March 2022 using PubMed and the Cochrane Library, identifying studies on the imaging features associated with H3 K27-altered and/or H3 G34-mutant gliomas.
Results
Forty-seven studies fulfilled the inclusion criteria, the majority on H3 K27-altered gliomas. Just under half (21/47) were case reports or short series, the remainder being diagnostic accuracy studies. Despite heterogeneous methodology, some themes emerged. In particular, enhancement of H3 K27M-altered gliomas is variable and can be less than expected given their highly malignant behavior. Low apparent diffusion coefficient values have been suggested as a biomarker of H3 K27-alteration, but high values do not exclude this genotype. Promising correlations between high relative cerebral blood volume values and H3 K27-alteration require further validation. Limited data on H3 G34-mutant gliomas suggest some morphologic overlap with 1p/19q-codeleted oligodendrogliomas.
Conclusions
The existing data are limited, especially for H3 G34-mutant gliomas and artificial intelligence techniques. Current evidence indicates that imaging-based predictions of HAG are insufficient to replace histological assessment. In particular, H3 K27-altered gliomas should be considered when occurring in typical midline locations irrespective of enhancement characteristics.
Citation
Lasocki, A., Abdalla, G., Chow, G., & Thust, S. C. (2022). Imaging features associated with H3 K27-altered and H3 G34-mutant gliomas: a narrative systematic review. Cancer Imaging, 22, Article 63. https://doi.org/10.1186/s40644-022-00500-3
Journal Article Type | Article |
---|---|
Acceptance Date | Oct 23, 2022 |
Online Publication Date | Nov 17, 2022 |
Publication Date | Nov 17, 2022 |
Deposit Date | May 7, 2025 |
Publicly Available Date | May 16, 2025 |
Journal | Cancer Imaging |
Print ISSN | 1470-7330 |
Electronic ISSN | 1470-7330 |
Publisher | BioMed Central |
Peer Reviewed | Peer Reviewed |
Volume | 22 |
Article Number | 63 |
DOI | https://doi.org/10.1186/s40644-022-00500-3 |
Keywords | Magnetic resonance imaging, Radiogenomics, H3 K27M-altered glioma, H3 G34-mutant glioma |
Public URL | https://nottingham-repository.worktribe.com/output/20567528 |
Publisher URL | https://cancerimagingjournal.biomedcentral.com/articles/10.1186/s40644-022-00500-3 |
PMID | 36397143 |
Additional Information | Received: 30 August 2022; Accepted: 23 October 2022; First Online: 17 November 2022; : ; : Ethics committee approval was not required by our institutions.; : Not applicable.; : Nil. |
Files
Imaging Features Associated With H3 K27-altered And H3 G34-mutant Gliomas- A Narrative Systematic Review
(1.2 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
Copyright Statement
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which
permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the
original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or
other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line
to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data
You might also like
Neuro-Oncology
(2024)
Book Chapter
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search